Leukocyte Count Defines Patients on Risk for Thrombotic Complications with Well Controlled Essential Thrombocythemia- Data from a Patient- Registry
Veronika Buxhofer‐Ausch(Johannes Kepler University of Linz), Heinz Gisslinger(Medical University of Vienna), Róbert Královics(Medical University of Vienna), Ernst Schloegl(Hanusch Hospital), Siegfried Sormann(Medical University of Graz), Michael Steurer(Innsbruck Medical University)
Cited by 0
Related Papers
A Gain-of-Function Mutation of <i>JAK2</i> in Myeloproliferative Disorders
|New England Journal of Medicine|2005|3.5k
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
|Journal of Clinical Oncology|2011|540
Erythropoietin Treatment of Anemia Associated with Multiple Myeloma
|New England Journal of Medicine|1990|450